All Stories

  1. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery
  2. Particle size tailoring of ursolic acid nanosuspensions for improved anticancer activity by controlled antisolvent precipitation
  3. Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization
  4. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI)
  5. Kinetic Entrapment of a Hidden Curcumin Cocrystal with Phloroglucinol
  6. Assessment of the relative performance of a confined impinging jets mixer and a multi-inlet vortex mixer for curcumin nanoparticle production
  7. AMYLOID PLAQUES BINDING CURCUMIN CONJUGATED MAGNETIC NANOPARTICLES FOR DIAGNOSIS IN ALZHEIMER'S DISEASE TG2576 MICE
  8. Delivery of Poorly Soluble Compounds by Amorphous Solid Dispersions
  9. Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice
  10. Simultaneously Improving the Mechanical Properties, Dissolution Performance, and Hygroscopicity of Ibuprofen and Flurbiprofen by Cocrystallization with Nicotinamide
  11. Formulation of sustained-release microspheres of granulocyte macrophage colony stimulating factor by freezing-induced phase separation with dextran and encapsulation with blended polymers
  12. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound
  13. Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis , on beta-amyloid-induced toxicity in PC12 cells
  14. Removal of toxic aristolochic acid components from Aristolochia plants by supercritical fluid extraction
  15. Process‐Induced Phase Transformation of Berberine Chloride Hydrates
  16. Stability Assessment and Formulation Characterization
  17. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies
  18. Production and characterization of a spray-dried hydroxypropyl-β-cyclodextrin/quercetin complex
  19. Molecular Modeling of Flavonoid-β-Cyclodextrin Complexes
  20. Anti-hygroscopic effect of dextrans in herbal formulations
  21. Engineering of Pharmaceutical Materials: An Industrial Perspective
  22. Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization
  23. Influence of Operating Temperature and Pressure on the Polymorphic Transition of Salmeterol Xinafoate in Supercritical Fluids
  24. David James William Grant, M. A., D. Phil., D. Sc. (1937–2005)
  25. Particle Engineering for Pulmonary Drug Delivery
  26. Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications
  27. Lack of effect of β-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium
  28. Control of Physical Forms of Drug Particles for Pulmonary Delivery by Spray Drying and Supercritical Fluid Processing
  29. Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography
  30. Effect of Amino Acids on the Dispersion of Disodium Cromoglycate Powders
  31. Physicochemical and Structural Characterization of Quercetin-β-Cyclodextrin Complexes
  32. An improved thermoanalytical approach to quantifying trace levels of polymorphic impurity in drug powders
  33. Surface characterization of salmeterol xinafoate powders by inverse gas chromatography at finite coverage
  34. Pharmacogenetics and herb???drug interactions
  35. Omeprazole as a CYP2C19 Marker in Chinese Subjects: Assessment of Its Gene-Dose Effect and Intrasubject Variability
  36. Control of Physical Forms of Pharmaceutical Substances
  37. Formation of Composite Crystals by Precipitation in Supercritical CO 2
  38. Aerosolisation behaviour of micronised and supercritically-processed powders
  39. A Modified Two-Portion Absorption Model to Describe Double-Peak Absorption Profiles of Ranitidine
  40. Physical Properties of Supercritically-Processed and Micronised Powders for Respiratory Drug Delivery
  41. Pharmacokinetics of acetaminophen in Hong Kong Chinese subjects
  42. Hygroscopic Study of Glucose, Citric Acid, and Sorbitol Using an Electrodynamic Balance: Comparison with UNIFAC Predictions
  43. Verticine ethanol hydrate (2/1/1)
  44. High performance liquid chromatographic analysis of a novel aminoalkylpyridine anticonvulsant 2-(4-chlorophenyl)amino-2-(4-pyridyl)ethane
  45. Parameters affecting in-liquid drying microencapsulation and release rate of cefaclor
  46. Water activity of mixed organic and inorganic aerosols
  47. MATHEMATICAL EVALUATION OF THE INFLUENCE OF ADVERSE EFFECT ON THERAPEUTIC EFFICACY IN A DIRECT RESPONSE SYSTEM
  48. A study of the Mechanisms of Wet Spherical Agglomeration of Pharmaceutical Powders
  49. Modification of phenytoin crystals. II. influence of 3-propanoyloxymethyl-5,5-diphenylhydantoin on solution-phase crystallization and related crystal properties
  50. Modification of phenytoin crystals: influence of 3-acetoxymethyl-5,5-diphenylhydantoin on solution-phase crystallization and related crystal properties
  51. Influence of crystallization conditions on the physical properties of acetaminophen crystals: evaluation by multiple linear regression
  52. Physical factors influencing the aqueous dissolution rate of acetaminophen crystals doped with p-acetoxyacetanilide: evaluation by multiple linear regression
  53. Modification of acetaminophen crystals. III. Influence of initial supersaturation during solution-phase growth on crystal properties in the presence and absence of p-acetoxyacetanilide
  54. Modification of acetaminophen crystals. II. Influence of stirring rate during solution-phase growth on crystal properties in the presence and absence of p-acetoxyacetanilide
  55. Stability Assessment and Formulation Characterization